Actively Recruiting
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
Led by Ruijin Hospital · Updated on 2024-08-19
1000
Participants Needed
1
Research Sites
867 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to collect clinical data from adult patients with relapsed or refractory non-Hodgkin's lymphoma (r/r NHL) receiving cellular immunotherapy to establish a large database of cellular immunotherapy for Chinese patients.
CONDITIONS
Official Title
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with a confirmed diagnosis of relapsed or refractory B-cell or T-cell non-Hodgkin's lymphoma, including subtypes such as DLBCL, FL, MCL, HGBL-NOS, FL3b, MZL, and transformed lymphomas
- Patients who have received informed consent waivers
- Patients who have received or are currently receiving cellular immunotherapy products including cytokine-induced killer cell therapy (CIK), tumor-infiltrating lymphocytes (TIL), cytokine-induced killer cell-dendritic cell mixed therapy (DC-CIK), chimeric antigen receptor T cells, NK cells or macrophage therapy (CAR-T, CAR-NK, CAR-M), T-cell receptor chimeric T cell therapy (TCR-T), or dendritic cell therapy
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Actively Recruiting
Research Team
W
Weili Zhao
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here